Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
LSTA has been in the news recently: LISATA THERAPEUTICS is not directly mentioned in the provided information, but the landscape of biotechnology includes companies like Harmony Biosciences and Neurocrine Biosciences, which have received mixed analyst ratings recently. Additionally, advancements in cancer treatment are being pursued by companies such as Anixa Biosciences with its breast cancer vaccine and TuHURA Biosciences with its funding for trials.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
